TRiCares Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
28
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$50M
- Investors
-
9
TRiCares General Information
Description
Developer of catheter-based valve replacement system designed for minimally invasive treatment of tricuspid valve regurgitation. The company's medical devices address tricuspid insufficiency through their anatomical conformation and their simplicity of use, enabling patients to avail of effective and lasting cures to the problem of tricuspid insufficiency.
Contact Information
Website
www.tricares.comCorporate Office
- Heisenbergbogen 2
- 85609 Aschheim
- Germany
Corporate Office
- Heisenbergbogen 2
- 85609 Aschheim
- Germany
TRiCares Timeline
TRiCares Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series D) | 25-Jul-2024 | $50M | Completed | Generating Revenue | ||
4. Later Stage VC (Series C) | 15-Sep-2022 | Completed | Generating Revenue | |||
3. Later Stage VC (Series B) | 04-Jun-2018 | Completed | Generating Revenue | |||
2. Seed Round | 14-Sep-2015 | $2.2M | $2.2M | Completed | Startup | |
1. Angel (individual) | Completed | Startup |
TRiCares Comparisons
Industry
Financing
Details
TRiCares Competitors (21)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Open Stent Solution | Venture Capital-Backed | Dury, France | ||||
Emboline | Venture Capital-Backed | Santa Cruz, CA | ||||
ICS (Surgical Devices) | Venture Capital-Backed | Grand Rapids, MI | ||||
Keystone Heart | Private Equity-Backed | Caesarea, Israel | ||||
Direct Flow Medical | Venture Capital-Backed | Santa Rosa, CA |
TRiCares Patents
TRiCares Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4287991-A1 | Replacement heart valve prosthesis with a predefined passage | Pending | 03-Feb-2021 | ||
US-20240065831-A1 | Replacement heart valve prosthesis with a predefined passage | Pending | 03-Feb-2021 | ||
EP-4072473-A1 | Connecting device for medical devices | Pending | 13-Dec-2019 | ||
AU-2020403542-A1 | Connecting device for medical devices | Pending | 13-Dec-2019 | ||
CA-3157212-A1 | Connecting device for medical devices | Pending | 13-Dec-2019 | A61F2/2427 |
TRiCares Executive Team (6)
Name | Title | Board Seat |
---|---|---|
Ahmed Elmouelhi | President, Managing Director & Chief Executive Officer | |
Laura Ghione | Chief Operating Officer | |
Lubos Cechvala | Financial Director |
TRiCares Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Frederik Groenewegen | 415 Capital | Board Member | |
Leila Nicolas | GO Capital (France) | Board Member | |
Sofia Ioannidou Ph.D | Andera Partners | Board Member | |
Thomas Möller Ph.D | BioMedPartners | Board Observer |
TRiCares Signals
TRiCares Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
415 Capital | Venture Capital | Minority | ||
Bayern Kapital | Venture Capital | Minority | ||
Andera Partners | PE/Buyout | Minority | ||
BioMedPartners | Venture Capital | Minority | ||
Crédit Mutuel Equity | Growth/Expansion | Minority |
TRiCares FAQs
-
When was TRiCares founded?
TRiCares was founded in 2013.
-
Who is the founder of TRiCares?
Pascal Lim MD and Coralie Marchand are the founders of TRiCares.
-
Who is the CEO of TRiCares?
Ahmed Elmouelhi is the CEO of TRiCares.
-
Where is TRiCares headquartered?
TRiCares is headquartered in Aschheim, Germany.
-
What is the size of TRiCares?
TRiCares has 28 total employees.
-
What industry is TRiCares in?
TRiCares’s primary industry is Surgical Devices.
-
Is TRiCares a private or public company?
TRiCares is a Private company.
-
What is TRiCares’s current revenue?
The current revenue for TRiCares is
. -
How much funding has TRiCares raised over time?
TRiCares has raised $129M.
-
Who are TRiCares’s investors?
415 Capital, Bayern Kapital, Andera Partners, BioMedPartners, and Crédit Mutuel Equity are 5 of 9 investors who have invested in TRiCares.
-
Who are TRiCares’s competitors?
Open Stent Solution, Emboline, ICS (Surgical Devices), Keystone Heart, and Direct Flow Medical are some of the 21 competitors of TRiCares.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »